|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 233/64 | |
| C07K 14/605 |
| (11) | Number of the document | 3000482 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15188731.2 |
| Date of filing the European patent application | 2010-12-16 | |
| (97) | Date of publication of the European application | 2016-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 09179390 | 2009-12-16 | EP | |
| 288601 P | 2009-12-21 | US |
| (72) |
SAUERBERG, Per, DK
LAU, Jesper, DK
LINDEROTH, Lars, DK
KODRA, Jįnos Tibor, DK
SPETZLER, Jane, DK
GARIBAY, Patrick William, DK
|
| (73) |
Novo Nordisk A/S,
Corporate Patents Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | DOUBLE-ACYLATED GLP-1 DERIVATIVES |
| DOUBLE-ACYLATED GLP-1 DERIVATIVES |